• Home
  • Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

Author List
Petrylak DP, Tangen CM, Hussain MH, Lara PN, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED
Publication
The New England journal of medicine
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1440701
Publication Year
2004
PubMed ID
15470214
Publication Title
Petrylak DP, Tangen CM, Hussain MH, Lara PN, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004 Oct 07; 351(15):1513-20.